{"transactions":[{"id":878858,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:31:36.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":202000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 26, 2026, the reporting person was awarded 202,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date."}],"balance_after":684970,"source":{"system":"sec-edgar","filing":"0001477932-26-001101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001101/form4.xml","form_type":"4"}},{"id":932898,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-23T21:06:55.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":49200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 164,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 49,200 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 16,400 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 114,800 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":482970,"source":{"system":"sec-edgar","filing":"0001477932-26-000366","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000366/form4.xml","form_type":"4"}},{"id":1063248,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-19T20:06:32.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":26143,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 15, 2025, the reporting person was awarded 26,143 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two installments of 13,072 units and 13,071 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date."}],"balance_after":533770,"source":{"system":"sec-edgar","filing":"0001477932-25-006103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225006103/form4.xml","form_type":"4"}},{"id":1081715,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-25T20:01:29.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received 100,000 restricted stock units under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of a closing stock price target above $2.50 per share of the Issuer's common stock for a minimum of thirty consecutive trading days prior to July 24, 2028, which date shall be no earlier than July 24, 2026, and also subject to time-based vesting in a single installment six months after the timely achievement of the target, if at all."}],"balance_after":507627,"source":{"system":"sec-edgar","filing":"0001477932-25-005251","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225005251/form4.xml","form_type":"4"}},{"id":1126734,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:05:51.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":17406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 1, 2025, the reporting person was awarded 17,406 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three equal installments of 5,802 units on each of June 1, 2025, July 1, 2025 and August 1, 2025, respectively, are also subject to further time-based vesting in a single installment on August 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":407627,"source":{"system":"sec-edgar","filing":"0001477932-25-004367","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004367/form4.xml","form_type":"4"}},{"id":1233960,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-04T21:01:11.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":13969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 1, 2025, the reporting person was awarded 13,969 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 4,657 units, 4,656 units, and 4,656 units on each of March 1, 2025, April 1, 2025 and May 1, 2025, respectively, are also subject to further time-based vesting in a single installment on March 1, 2026, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":390221,"source":{"system":"sec-edgar","filing":"0001477932-25-001455","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225001455/form4.xml","form_type":"4"}},{"id":1346414,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-03T21:01:19.000Z","date":"2024-12-01","kind":"grant","planned":false,"acquired":true,"shares":12683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 1, 2024, the reporting person was awarded 12,683 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 4,228 units, 4,228 units, and 4,227 units on each of December 1, 2024, January 1, 2025 and February 1, 2025, respectively, are also subject to further time-based vesting in a single installment on July 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":376252,"source":{"system":"sec-edgar","filing":"0001477932-24-007801","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224007801/form4.xml","form_type":"4"}},{"id":1417080,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-04T20:02:34.000Z","date":"2024-09-01","kind":"grant","planned":false,"acquired":true,"shares":13493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 1, 2024, the reporting person was awarded 13,493 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 4,498 units, 4,498 units, and 4,497 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":363569,"source":{"system":"sec-edgar","filing":"0001477932-24-005498","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224005498/form4.xml","form_type":"4"}},{"id":1432053,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-08-16T20:05:21.000Z","date":"2024-08-15","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On Sept 28, 2023, the reporting person was awarded 78,000 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to Dec 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 19,500 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 6,500 units on each of Sept 28, 2024, 2025 and 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in Jan 2024, the rights with respect to 33,150 RSUs subject to the award previously vested and remain subject to time-based vesting. The rights with respect to the remaining 25,350 RSUs did not vest and were cancelled on August 15, 2024."}],"balance_after":350076,"source":{"system":"sec-edgar","filing":"0001477932-24-005022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224005022/form4.xml","form_type":"4"}},{"id":1494252,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-04T20:05:42.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":11686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 1, 2024, the reporting person was awarded 11,686 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 3,896 units, 3,895 units, and 3,895 units on each of June 1, 2024, July 1, 2024 and August 1, 2024, respectively, are also subject to further time-based vesting in a single installment on May 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":330576,"source":{"system":"sec-edgar","filing":"0001477932-24-003481","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224003481/form4.xml","form_type":"4"}},{"id":1670356,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-26T21:02:36.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":33150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 28, 2023, the reporting person was awarded 78,000 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 33,150 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 11,050 units on each of September 28, 2024, September 28, 2025 and September 28, 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":318890,"source":{"system":"sec-edgar","filing":"0001477932-24-000404","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224000404/form4.xml","form_type":"4"}},{"id":1757199,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-20T20:05:03.000Z","date":"2023-10-19","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 19, 2023, the reporting person was awarded 100,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of a closing stock price target above $5.00 per share of the Issuer's common stock for a minimum of thirty consecutive trading days prior to October 19, 2026, and also subject to time-based vesting in a single installment six months after the timely achievement of the target, if at all.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":285740,"source":{"system":"sec-edgar","filing":"0001477932-23-007775","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223007775/form4.xml","form_type":"4"}},{"id":1833384,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-07T20:03:09.000Z","date":"2023-07-05","kind":"grant","planned":false,"acquired":true,"shares":24750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 4, 2022, the reporting person was awarded 55,000 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 24,750 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 8,250 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in October 2022 and January 2023 respectively, the rights with respect to 9,625 RSUs and 20,625 RSUs subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":185740,"source":{"system":"sec-edgar","filing":"0001477932-23-005120","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223005120/form4.xml","form_type":"4"}},{"id":2055405,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-13T21:03:57.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":20625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 4, 2022, the reporting person was awarded 55,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 20,625 restricted stock units vesting.  The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 6,875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.  As reported in October 2022, the rights with respect to 9,625 restricted stock units subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":160990,"source":{"system":"sec-edgar","filing":"0001477932-23-000276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223000276/form4.xml","form_type":"4"}},{"id":2137427,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-10-14T20:08:47.000Z","date":"2022-10-13","kind":"grant","acquired":true,"shares":9625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 4, 2022, the reporting person was awarded 55,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 9,625 restricted stock units vesting.  The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three installments of 3,209 units, 3,208 units, and 3,208 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":140365,"source":{"system":"sec-edgar","filing":"0001477932-22-007703","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222007703/form4.xml","form_type":"4"}},{"id":2141711,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-10-06T20:05:42.000Z","date":"2022-10-04","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 4, 2022, the reporting person was awarded 100,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of a closing stock price target above $5.00 per share of the Issuer's common stock for a minimum of ten consecutive trading days prior to October 4, 2025, and also subject to time-based vesting in a single installment six months after the timely achievement of the target, if at all.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":130740,"source":{"system":"sec-edgar","filing":"0001477932-22-007485","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222007485/form4.xml","form_type":"4"}},{"id":2222580,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T20:01:11.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":36821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 3, 2021, the reporting person was granted an option to purchase 56,647 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 36,821 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two installments of 18,411 shares and 18,410 shares on each of August 3, 2022 and August 3, 2023, respectively.  As reported in April 2022, the rights with respect to the remaining 19,826 shares subject to the award previously vested and remain subject to time-based vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On August 3, 2021, the reporting person was granted an option to purchase 56,647 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 36,821 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two installments of 18,411 shares and 18,410 shares on each of August 3, 2022 and August 3, 2023, respectively.  As reported in April 2022, the rights with respect to the remaining 19,826 shares subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":56647,"derivative":{"exercise_price":3.4,"expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":36821},"source":{"system":"sec-edgar","filing":"0001477932-22-004652","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222004652/form4.xml","form_type":"4"}},{"id":2222579,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-24T20:01:11.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":19981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 3, 2021, the reporting person was awarded 30,740 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 19,981 restricted stock units vesting.  The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two installments of 9,991 units and 9,990 units on each of August 3, 2022 and August 3, 2023, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.  As reported in April 2022, the rights with respect to the remaining 10,759 restricted stock units subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":30740,"source":{"system":"sec-edgar","filing":"0001477932-22-004652","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222004652/form4.xml","form_type":"4"}},{"id":2300901,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-08T20:06:16.000Z","date":"2022-04-07","kind":"grant","acquired":true,"shares":19826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 3, 2021, the reporting person was granted an option to purchase 56,647 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 19,826 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 9,913 shares on each of August 3, 2022 and August 3, 2023, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On August 3, 2021, the reporting person was granted an option to purchase 56,647 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 19,826 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 9,913 shares on each of August 3, 2022 and August 3, 2023, respectively."}],"balance_after":19826,"derivative":{"exercise_price":3.4,"expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":19826},"source":{"system":"sec-edgar","filing":"0001477932-22-002189","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222002189/form4.xml","form_type":"4"}},{"id":2300900,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-04-08T20:06:16.000Z","date":"2022-04-07","kind":"grant","acquired":true,"shares":10759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 3, 2021, the reporting person was awarded 30,740 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 10,759 restricted stock units vesting.  The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two installments of 5,379 units and 5,380 units on each of August 3, 2022 and August 3, 2023, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":10759,"source":{"system":"sec-edgar","filing":"0001477932-22-002189","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222002189/form4.xml","form_type":"4"}},{"id":2887731,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64384,"kind":"person","name":"Hughes Terig","position":1,"cik":"0001841309","reported_name":"Hughes Terig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrant (Right to Buy)","published_at":"2021-02-02T21:44:24.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On February 1, 2021, the Reporting Person was granted a warrant to purchase up to 185,000 shares of Common Stock of the issuer at an exercise price of $4.90 per share.  The warrant will vest in full twelve months from the date of grant (subject to continuous employment through such date)."},{"field":"shares","element":"transactionShares","label":"F1","text":"On February 1, 2021, the Reporting Person was granted a warrant to purchase up to 185,000 shares of Common Stock of the issuer at an exercise price of $4.90 per share.  The warrant will vest in full twelve months from the date of grant (subject to continuous employment through such date)."}],"balance_after":185000,"derivative":{"exercise_price":4.9,"exercise_date":"2022-02-01","expiration_date":"2027-02-01","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001078782-21-000087","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878221000087/primary_doc.xml","form_type":"4"}}]}